Verastem, Inc (VSTM) CEO Robert Forrester on Q4 2018 Results - Earnings Call Transcript [Seeking Alpha]
Verastem, Inc. (VSTM)
Last verastem, inc. earnings: 10/29 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
verastem.com
Company Research
Source: Seeking Alpha
Verastem, Inc (VSTM) CEO Robert Forrester on Q4 2018 Results - Earnings Call Transcript Verastem, Inc (NASDAQ: VSTM Company Participants Robert Forrester - CEO Rob Gagnon - Chief Financial Officer Joseph Lobacki - Chief Commercial Officer Dan Paterson - Chief Operating Officer Conference Call Participants Erin Cox - Senior Director of Investor Relations & Corporate Communications Jake Colby - BTIG Matthew Cross - Jones Trading Swayampaukula Ramakanth - H.C. Wainwright George Zavoico - B. Riley FBR Operator Good afternoon, and welcome to the Verastem Oncology Investor Conference Call on Tuesday, March 12, 2019. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request and will be available on the company’s website for a period of 90 days from today. At this time, I would like to introduce Ms. Erin Cox, Senior Director of Investor Relations & Corporate Commu
Show less
Read more
Impact Snapshot
Event Time:
VSTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VSTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VSTM alerts
High impacting Verastem, Inc. news events
Weekly update
A roundup of the hottest topics
VSTM
News
- Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business UpdatesBusiness Wire
- Verastem Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceBusiness Wire
- Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical OfficerBusiness Wire
- Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
VSTM
Earnings
- 5/9/24 - Beat
VSTM
Sec Filings
- 5/9/24 - Form 10-Q
- 4/12/24 - Form DEF
- 4/9/24 - Form 8-K
- VSTM's page on the SEC website